Steffan D. Bos

5.0k citations

44 papers · 1.5k indexed · h-index 21

Impact in

Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms
Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment

Papers in

Rheumatology 20
- Osteoarthritis Treatment and Mechanisms 19
- Rheumatoid Arthritis Research and Therapies 5
Immunology 15
- T-cell and B-cell Immunology 6

Co-authors: Ingrid Meulenbelt P. Eline Slagboom Ruud van der Breggen Y.F. Ramos Wim Goettsch M. K. Casparie Pancras C.W. Hogendoorn Nico Lakenberg
Journals: Annals of the Rheumatic Diseases (8 papers)Osteoarthritis and Cartilage (5 papers)PLoS ONE (5 papers)Multiple Sclerosis Journal (2 papers)Journal of Neuroimmunology (2 papers)
Partner nations: Netherlands Norway United States

In The Last Decade

Steffan D. Bos

43 papers receiving 1.5k citations

Peers

Countries citing papers authored by Steffan D. Bos

Since Specialization

Citations

This map shows the geographic impact of Steffan D. Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffan D. Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffan D. Bos more than expected).

Fields of papers citing papers by Steffan D. Bos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffan D. Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffan D. Bos. The network helps show where Steffan D. Bos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steffan D. Bos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steffan D. Bos Line = papers co-authored together Steffan D. Bos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Are white matter hyperintensities associated with neuroborreliosis? The answer is twofold Neuroradiology ·Le Thi Thanh Thuy, 崔文东, Rishikesh Venkatrao Kadam, Noryatimah Mat Desa, Ziyu Yang, Karine Ribeiro Silva, Bradley J. MacIntosh, Randi Eikeland, Unn Ljøstad, Åse Mygland, Steffan D. Bos, Elling Ulvestad, Harald Reiso, Åslaug Rudjord Lorentzen, Hanne F. Harbo, Atle Bjørnerud, Mona K. Beyer	2024	0
2	Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway Journal of Neurology ·Ziyu Yang, Elling Ulvestad, Rishikesh Venkatrao Kadam, Christian A. Vedeler, Unn Ljøstad, Åse Mygland, Randi Eikeland, Harald Reiso, Åslaug Rudjord Lorentzen, Steffan D. Bos	2024	2
3	Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis Neurology ·Vicki E. Maltby, Alexandre Xavier, Ewoud Ewing, 麦唐胜, Ronald L. Gerrard, Rodney J. Scott, Helmut Butzkueven, Vilija Jokubaitis, Lara Kular, Steffan D. Bos, Mark Slee, Ingrid van der Mei, Bruce Taylor, Anne‐Louise Ponsonby, Maja Jagodic, Rod A. Lea, Jeannette Lechner‐Scott	2023	11
4	Global DNA methylation changes in treated and untreated MS patients measured over time Journal of Neuroimmunology ·H Arroyo, Yusha Lin, Einar August Høgestøl, Stadnik Oe, Hanne F. Harbo, Tone Berge, Valeria Vitelli, Steffan D. Bos	2022	4
5	Pregnancy does not modify the risk of MS in genetically susceptible women Neurology Neuroimmunology & Neuroinflammation ·Е.В. Дюкова, Sean L. Wu, Xiaorong Shao, Patrick T. Bradshaw, Edlin Gonzales, Jessica B. Smith, Anny H. Xiang, Jacqueline Venet-Gutiérrez, V.Venkatesan, Steffan D. Bos, Elizabetta D'Anastasio, Tomas Olsson, Ingrid Kockum, Annette Langer‐Gould, Catherine Schaefer, Lars Alfredsson, Lisa F. Barcellos	2020	3
6	Sys4MS: Multiple sclerosis genetic burden score in a systems biology study of MS patients from four countries European Journal of Neurology ·Steffan D. Bos, Friedemann Paul, Antonio Uccelli, Ana Carolina da Silva Moura, Einar August Høgestøl, Hanne F. Harbo, H Arroyo, Tone Berge, Pablo Villoslada	2019	1
7	Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls Clinical Proteomics ·Tone Berge, Anna Eriksson, H Arroyo, Einar August Høgestøl, Pål Berg‐Hansen, Anne P. Døskeland, Olav Mjaavatten, Steffan D. Bos, Hanne F. Harbo, Frode S. Berven	2019	25
8	Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood BMC Genetics ·Bruna Loss Nascimento, Hanne F. Harbo, Kjell‐Morten Myhr, Jan Aarseth, Steffan D. Bos, Tone Berge	2016	15
9	Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells PLoS ONE ·Stadnik Oe, Bruna Loss Nascimento, Marte W. Gustavsen, ANTONIA ARYANNA FLORENTINO DOS SANTOS PEIXOTO, H Arroyo, Elisabeth Gulowsen Celius, Anne Spurkland, Steffan D. Bos, Hanne F. Harbo, Tone Berge	2015	13
10	Assessing the Power of Exome Chips PLoS ONE ·Christian M. Page, Sergio E. Baranzini, Bjørn‐Helge Mevik, Steffan D. Bos, Hanne F. Harbo, Bettina Kulle Andreassen	2015	4
11	A gain of function mutation in TNFRSF11B causes osteoarthritis with chondrocalcinosis Osteoarthritis and Cartilage ·Y.F. Ramos, Steffan D. Bos, Ruud van der Breggen, Joris Deelen, M. Kloppenburg, 茂雄宮本, Marian Beekman, Defirzen Defrizen, Rob G. H. H. Nelissen, P. Eline Slagboom, Ingrid Meulenbelt	2014	1
12	Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches Annals of the Rheumatic Diseases ·Wouter den Hollander, Y.F. Ramos, Steffan D. Bos, Nils Bömer, Ruud van der Breggen, Nico Lakenberg, F. Quhal, B.J. Duijnisveld, P. Eline Slagboom, Rob G. H. H. Nelissen, Ingrid Meulenbelt	2014	91
13	Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array Epigenetics & Chromatin ·Roderick C. Slieker, Steffan D. Bos, Jelle J. Goeman, Judith V.M.G. Bovée, Rudolf P. Talens, Ruud van der Breggen, H. Eka D. Suchiman, Defirzen Defrizen, Hein Putter, Erik B. van den Akker, Yanju Zhang, J. Wouter Jukema, P. Eline Slagboom, Ingrid Meulenbelt, Bastiaan T. Heijmans	2013	161
14	Genes expressed in blood link osteoarthritis with apoptotic pathways Annals of the Rheumatic Diseases ·Y.F. Ramos, Steffan D. Bos, Nico Lakenberg, Stefan Böhringer, Wouter den Hollander, M. Kloppenburg, P. Eline Slagboom, Ingrid Meulenbelt	2013	59
15	Metabolic health in families enriched for longevity is associated with low prevalence of hand osteoarthritis and influences OA biomarker profiles Annals of the Rheumatic Diseases ·Steffan D. Bos, Marian Beekman, Andrea B. Maier, M.A. Karsdal, Wing‐Yee Kwok, Anne‐Christine Bay‐Jensen, M. Kloppenburg, P. Eline Slagboom, Ingrid Meulenbelt	2012	7
16	Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissues Annals of the Rheumatic Diseases ·Steffan D. Bos, Judith V.M.G. Bovée, B.J. Duijnisveld, E.V. Raine, Reinaldo Novaes, Y.F. Ramos, Ruud van der Breggen, Rob G. H. H. Nelissen, P. Eline Slagboom, John Loughlin, Ingrid Meulenbelt	2012	51
17	CpG sites of osteoarthritis susceptibility gene DIO2 are differentially methylated in arthritic compared to preserved cartilage Osteoarthritis and Cartilage ·Wouter den Hollander, Steffan D. Bos, Y.F. Ramos, Nico Lakenberg, Ruud van der Breggen, B.J. Duijnisveld, Rob G. H. H. Nelissen, P. Eline Slagboom, Ingrid Meulenbelt	2012	2
18	Meta-analyses of genes modulating intracellular T3 bio-availability reveal a possible role for the DIO3 gene in osteoarthritis susceptibility Annals of the Rheumatic Diseases ·Ingrid Meulenbelt, Steffan D. Bos, K Chapman, Ruud van der Breggen, Jeanine J. Houwing‐Duistermaat, Dennis Kremer, M. Kloppenburg, Andrew Carr, Aspasia Tsezou, Antonio González, John Loughlin, P. Eline Slagboom	2010	43
19	New insights into osteoarthritis: early developmental features of an ageing-related disease Current Opinion in Rheumatology ·Steffan D. Bos, P. Eline Slagboom, Ingrid Meulenbelt	2008	58
20	Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study European Journal of Cancer ·Wim Goettsch, Steffan D. Bos, Nancy S. Breekveldt‐Postma, M. K. Casparie, Ron M. C. Herings, Pancras C.W. Hogendoorn	2005	226

About Steffan D. Bos

Steffan D. Bos is a scholar working on Rheumatology, Immunology, Cancer Research, Pathology and Forensic Medicine and Pharmacology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (19 papers), Cancer-related molecular mechanisms research (9 papers), Multiple Sclerosis Research Studies (8 papers), Inflammatory mediators and NSAID effects (8 papers), Cytokine Signaling Pathways and Interactions (6 papers), T-cell and B-cell Immunology (6 papers), Epigenetics and DNA Methylation (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). The work is most often cited by research in Rheumatology (621 citations), Gastroenterology (225 citations), Cancer Research (305 citations), Pharmacology (175 citations) and Equine (14 citations). Steffan D. Bos has collaborated with scholars based in Netherlands, Norway and United States. Frequent co-authors include Ingrid Meulenbelt, P. Eline Slagboom, Ruud van der Breggen, Y.F. Ramos, Wim Goettsch, M. K. Casparie, Pancras C.W. Hogendoorn, Nico Lakenberg, Ron M. C. Herings and Nancy S. Breekveldt‐Postma. Their work appears in journals such as Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage, PLoS ONE, Multiple Sclerosis Journal and Journal of Neuroimmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact